483
NovaSignal Corp.NovaSignal Corp. – FDA 483, Nov 1, 2017
Record Details
NEURAL ANALYTICS in Los Angeles, CA, a medical device manufacturer, was inspected by the FDA. The inspection revealed significant deficiencies in design control procedures, specifically regarding the establishment of adequate design inputs for their Lucid M1 Transcranial Doppler Ultrasound system. Additionally, the firm's risk analysis for the Lucid M1 system was found to be incomplete, failing to assess critical risks related to calculated values and measurements.
View Company Profile
ID · e4c94374-3950-4705-860b-7a7f88a2187d
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.